In the past two decades, the incidence of Inflammatory Bowel Disease (IBD) has been increasing in Asia. Our recent epidemiology study across nine countries in Asia-Pacific showed that Hong Kong and Macau are among the top three regions with the highest incidence of IBD. The incidence of Hong Kong was 3.0 per 100,000. There has been a three-fold increase in the incidence of IBD patients in Hong Kong from 1.0 in 1991-2001 to 3.0 per 100,000 in 2013. Complicated and penetrating Crohn’s disease is common in Asia.

Due to the lack of systematic data collection of IBD in Hong Kong, its diagnosis may be delayed because of poor awareness among physicians and patients.

The Nixon-TAM (Twin and Multiplex) Hong Kong IBD Registry aims to investigate the prevalence, disease characteristics, treatment, and prognosis of IBD patients in Hong Kong. 13 public hospitals will participate in the registry.

If you are an IBD or suspected IBD patient, and would like join the registry please call 26321519 or click here

If you are a clinician who would like to refer patients who may be interested in joining the registry please contact us at 26321519